NIH Grants and Funding Opportunities
Browse open NIH grants, research funding, and fellowships, with guidance on mechanisms like R01, R21, and R03 and how to pick the right one.
NIH funding is a system with its own vocabulary, and learning it is the fastest way to stop wasting cycles. Awards are organized by mechanism: R-series research grants (the flagship R01 for mature projects, R21 for exploratory ideas, R03 for small studies), K-series career development awards, F-series fellowships for trainees, and small-business programs. Each mechanism carries fixed expectations about preliminary data, project scope, duration, and career stage, so choosing the mechanism is really choosing the standard your application will be judged against.
The second structural fact is that the NIH is not one funder but a collection of institutes and centers, each with its own scientific priorities and paylines. The same proposal can be a strong fit at one institute and unfundable at another. Before writing, identify which institute’s mission covers your question, and consider contacting the relevant program officer, who can tell you whether the fit is real. That conversation is normal and expected, not an imposition.
Timing is rigid. Standard due dates recur in cycles, review takes months, and resubmission after a first rejection is a routine part of the process rather than a failure signal. Read the summary statement carefully, address the critiques, and come back stronger. Early-stage investigators should also check whether special payline considerations or career-stage programs apply to them.
Common mistakes include aiming an R01-sized idea at an R21, ignoring the specific funding opportunity announcement in favor of generic advice, and missing institutional deadlines that precede the NIH deadline. Use the live listings below to find open NIH opportunities, then read the full announcement on the official NIH site and confirm mechanism, institute fit, and due dates before drafting.
Current matching opportunities
These listings are limited to open, rolling, or upcoming opportunities that match this guide. Check the official source before applying.
NIH SBIR/STTR Omnibus Solicitation
NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) opportunities for early-stage biomedical commercialization.
NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) 2026-2029
NIH PA-26-002 supports funded international research collaborations led by a U.S. domestic prime organization, with foreign work proposed as linked International Project components under the PF5 mechanism.
NIH Director's Pioneer Award FY2028 Forecast and FY2027 Reference
NIH has forecast the FY2028 Director's Pioneer Award, with an estimated September 9, 2027 due date, but is not yet soliciting applications. This page explains the forecast and preserves FY2027 terms as historical reference; the full FY2028 announcement has not been published.
RFA-OD-25-010: Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
NIH/ORIP’s NIH-wide R24 opportunity funds development and improvement of broadly useful biomedical models, methods, and biological materials that can serve multiple NIH Institutes and Centers across multiple organ systems.
RFA-NS-25-023: HEAL Initiative Studies to Enable Analgesic Discovery (R61/R33, Clinical Trial Not Allowed)
NIH HEAL funds preclinical translational work to build stronger evidence for non-addictive analgesic discovery through a two-stage R61/R33 mechanism with no clinical trials and strict peer-review criteria.
RFA-ES-27-004: Superfund Hazardous Substance Research and Training Program (P42, Clinical Trial Optional)
NIEHS supports integrated, multi-project Superfund Research Program centers combining biomedical and environmental science and engineering to address hazardous-substance health effects, risk, detection, and remediation. The next published application due date is September 25, 2027.
NIH SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional): PAR-27-098
A late-stage small business commercialization bridge for U.S. NIH SBIR or STTR Phase II projects that need outsourced technical development, clinical studies, or market-readiness work before full commercialization.
PAR-27-077: NIH Science Education Partnership Award (SEPA) (R25 Clinical Trial Not Allowed)
The NIH reissued PAR-27-077 SEPA to fund pre-K through grade 12 STEM education projects that increase biomedical research understanding and encourage long-term science pathways.
PAR-25-415: Support for Research Excellence First Independent Research (SuRE-First) Award (R16)
NIH NIGMS SuRE-First grants provide competitive direct research funding to first-time independent faculty at resource-limited U.S. institutions to build research capacity and involve students in biomedical research.
NICHD Resource Program Grants in Bioinformatics (PAR-24-301; P41 Clinical Trial Not Allowed)
NIH's NICHD P41 funding opportunity supports mature bioinformatics resources for developmental biology and birth-defects research using animal models through multi-component infrastructure and community-oriented tools, data, and training.
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional): PA-27-102
Open NIH parent STTR notice for eligible U.S. small businesses working with a nonprofit research institution; the next standard receipt date is January 5, 2027, and late applications are not accepted.
NIH PA-27-101: SBIR Phase IIB Strategic Breakthrough Award
NIH's Phase IIB Strategic Breakthrough award funds later-stage R&D for qualifying prior NIH SBIR or STTR Phase II projects, with a required 100% third-party match. The active notice's next listed application due date is January 5, 2027, at 5:00 p.m. applicant-organization local time.
Application guidance
Use the listings above as a shortlist, then build your application from the official instructions. Save the source page, deadline, eligibility rules, required documents, contact details, and any program-specific scoring criteria. If the deadline is rolling, apply early enough for review queues and budget limits. If the deadline is fixed, work backward from the closing date and leave time for recommendations, institutional approvals, financial documents, and portal errors.
Popular funding types
Popular locations
NIH Grants and Funding Opportunities FAQ
What do the NIH mechanism codes like R01 and R21 mean?
They identify the type of award: R01 is the standard multi-year research project grant, R21 supports exploratory work, and R03 funds small projects. Each mechanism has its own scope, duration, and page limits described on the official NIH website.
Can I apply to the NIH as an independent researcher?
Most NIH research grants are awarded to institutions, so investigators apply through a university, hospital, or eligible organization. Fellowships and some small-business programs have different rules, listed in each funding announcement.
Where do NIH applications get submitted?
Through official federal systems such as ASSIST or Grants.gov, following the specific funding opportunity announcement. Always work from the current announcement on the NIH site, not a cached or third-party copy.